Tate & Lyle PLC (OTCMKTS:TATYY - Get Free Report) was the target of a large decline in short interest in July. As of July 31st, there was short interest totaling 1,200 shares, adeclineof53.8% from the July 15th total of 2,600 shares. Based on an average daily trading volume, of 1,700 shares, the short-interest ratio is presently 0.7 days. Currently,0.0% of the company's stock are sold short. Currently,0.0% of the company's stock are sold short. Based on an average daily trading volume, of 1,700 shares, the short-interest ratio is presently 0.7 days.
Tate & Lyle Trading Down 0.8%
TATYY opened at $28.98 on Friday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.21 and a current ratio of 2.16. The company's 50-day moving average is $29.29 and its 200 day moving average is $29.21. Tate & Lyle has a fifty-two week low of $24.61 and a fifty-two week high of $44.76.
Tate & Lyle Increases Dividend
The business also recently announced a dividend, which was paid on Wednesday, August 6th. Stockholders of record on Monday, June 23rd were given a dividend of $0.6696 per share. The ex-dividend date of this dividend was Friday, June 20th. This represents a dividend yield of 319.0%. This is an increase from Tate & Lyle's previous dividend of $0.33.
Analyst Upgrades and Downgrades
TATYY has been the topic of several recent research reports. Citigroup upgraded Tate & Lyle from a "hold" rating to a "strong-buy" rating in a report on Friday, May 16th. Barclays raised Tate & Lyle from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, April 22nd. Finally, UBS Group raised shares of Tate & Lyle to a "hold" rating in a research report on Tuesday, June 24th.
View Our Latest Report on TATYY
About Tate & Lyle
(
Get Free Report)
Tate & Lyle PLC, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. It operates through three segments: Food & Beverage Solutions, Sucralose, and Primary Products.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tate & Lyle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tate & Lyle wasn't on the list.
While Tate & Lyle currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.